Loxo Oncology, Inc. total revenue, net income and dynamics of changes in US dollar today
The dynamics of net revenue of Loxo Oncology, Inc. decreased. The change amounted to -131 000 $. The dynamics of net revenue is shown in comparison with the previous report. Net income of Loxo Oncology, Inc. today amounted to -27 064 000 $. Net income, revenue and dynamics - the main financial indicators of Loxo Oncology, Inc.. Graph of finance company Loxo Oncology, Inc.. Loxo Oncology, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of "net income" Loxo Oncology, Inc. on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2018
42 470 000 $
-
-27 064 000 $
-
30/06/2018
42 601 000 $
-
-11 726 000 $
-
31/03/2018
38 429 000 $
-
-3 558 000 $
-
31/12/2017
21 300 000 $
-
-20 628 000 $
-
30/09/2017
0 $
-
-73 319 000 $
-
30/06/2017
0 $
-
-30 401 000 $
-
Show:
to
Loxo Oncology, Inc. financial report charts
The latest dates of Loxo Oncology, Inc. financial statements available online: 30/06/2017, 30/06/2018, 30/09/2018. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Loxo Oncology, Inc. for today is 30/09/2018. Total revenue Loxo Oncology, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Loxo Oncology, Inc. is 42 470 000 $
Loxo Oncology, Inc. quarterly report dates
Operating revenue Loxo Oncology, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Loxo Oncology, Inc. is 42 470 000 $ Operating income Loxo Oncology, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Loxo Oncology, Inc. is -30 322 000 $ Net income Loxo Oncology, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Loxo Oncology, Inc. is -27 064 000 $
Current assets Loxo Oncology, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Loxo Oncology, Inc. is 628 308 000 $ Total assets Loxo Oncology, Inc. refers to the total amount of assets owned by a person or entity. Total assets Loxo Oncology, Inc. is 659 228 000 $ Current cash Loxo Oncology, Inc. - the sum of all of the cash a company has on the date of report. Current cash Loxo Oncology, Inc. is 136 427 000 $
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
42 470 000 $
42 601 000 $
38 429 000 $
21 300 000 $
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
42 470 000 $
42 601 000 $
38 429 000 $
21 300 000 $
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-30 322 000 $
-14 696 000 $
-5 755 000 $
-22 107 000 $
-74 434 000 $
-30 913 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-27 064 000 $
-11 726 000 $
-3 558 000 $
-20 628 000 $
-73 319 000 $
-30 401 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
56 928 000 $
41 555 000 $
31 990 000 $
30 718 000 $
64 754 000 $
24 398 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
72 792 000 $
57 297 000 $
44 184 000 $
43 407 000 $
74 434 000 $
30 913 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
628 308 000 $
676 737 000 $
720 649 000 $
781 807 000 $
376 611 000 $
471 416 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
659 228 000 $
716 510 000 $
748 609 000 $
783 442 000 $
411 506 000 $
472 437 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
136 427 000 $
147 967 000 $
104 096 000 $
142 025 000 $
80 419 000 $
260 267 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
621 999 000 $
670 988 000 $
710 229 000 $
626 200 000 $
371 669 000 $
467 585 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
379 215 000 $
392 124 000 $
384 421 000 $
378 210 000 $
394 036 000 $
461 254 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-61 431 000 $
-34 918 000 $
109 767 000 $
221 197 000 $
-62 890 000 $
-23 868 000 $
Last revenue report of Loxo Oncology, Inc. was 30/09/2018. According to last financial report total revenue in Loxo Oncology, Inc. was 42 470 000 US dollar and changed by 0% since last year. Net income in Loxo Oncology, Inc. was -27 064 000 $ in last quartal, net income changes to 0%.
Total cash Loxo Oncology, Inc. - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank. Total cash Loxo Oncology, Inc. is 621 999 000 $ Cash flow Loxo Oncology, Inc. is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow Loxo Oncology, Inc. is -61 431 000 $
Loxo Oncology, Inc. stocks data
LOXO stock price
Loxo Oncology, Inc. stock price today, LOXO stock quote.
